PAPSS1 and neoplasm: Finally, PAPSS1/PAPSS2 synthetic lethality was confirmed in vivo, as demonstrated by a significant tumor growth reduction of UMUC3 tumors without PAPSS1 and PAPSS2 compared to control tumors lacking only PAPSS2 (Fig. 5e and Extended Data Fig. 4k).